Article info

Download PDFPDF
Correspondence on 'Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis' by Ravindran et al

Authors

  • Veronique Promelle Department of Ophthalmology and Visual Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Prakash Muthusami Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Stephanie N Kletke Department of Ophthalmology and Visual Sciences, The Hospital for Sick Children, Toronto, Ontario, CanadaDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Furqan Shaikh Department of Hematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Brenda L Gallie Department of Ophthalmology and Visual Sciences, The Hospital for Sick Children, Toronto, Ontario, CanadaDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Ashwin Mallipatna Department of Ophthalmology and Visual Sciences, The Hospital for Sick Children, Toronto, Ontario, CanadaDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ashwin Mallipatna, Department of Ophthalmology and Visual Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada; ashwin.mallipatna{at}sickkids.ca
View Full Text

Citation

Promelle V, Muthusami P, Kletke SN, et al
Correspondence on 'Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis' by Ravindran et al

Publication history

  • Received November 3, 2021
  • Accepted December 12, 2021
  • First published January 11, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.